Pharmatica

Deepankar Nayak speaking with Lisa Moneymaker, Chief Operating and Strategy Officer at Medidata, about AI adoption and clinical trial innovation on Pharmatica Digital Pulse.

How AI Is Shaping the Next Generation of Clinical Trials

In this Digital Pulse episode, Lisa Moneymaker, Chief Operating and Strategy Officer at Medidata, joins Deepankar Nayak to discuss how AI is shaping the next generation of clinical trials.

Trisha Pillay, host of The Digital Pulse, discussing biopharma data management and antibody discovery

Dr Helen Brooker, Director of Product and Clinical Data at Signant Health, discusses sensor-enhanced patient data and wearable technology in clinical trials.

In the recent episode of the Digital Pulse podcast, host Shubhangi Dua was joined by Clara Toombs, Founder at Fertilia AI; Caroline Biddle, Founder at Working Through Fertility; and Dr Divpreet Sacha, Neko Health GP, Co-Founder at HHEI (The Hormonal Health Equity Initiative) and Digital Safety Officer.

In the recent episode of The Clinical Compass podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, is joined by Dr Amber Hill, Founder and CEO of Research Grid. They talk about how pharmaceutical companies and their leaders should approach the use of AI in clinical trials.

In this special Scientific Council Spotlight episode of The Discovery Loop podcast, host Shubhangi Dua, Journalist, Podcast Producer and Podcast Host at Pharmatica.io, sits down with Deepankar Nayak, the CEO of Deep Longevity. Nayak also serves on Pharmatica’s Scientific Council.

In the recent episode of The Discovery Loop podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io, sat down with Diana Andrade, Founder & Managing Director at RD Privacy and Data Protection Officer (DPO) for Biopharma and Life Sciences. They talk about the current state of data protection regulations and how enterprises can innovate responsibly.

In the recent episode of The Chain Reaction podcast, Nour AlSaleh, Founder and CEO of Veragence Pharma Consultancy, sat down with host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io and EM360Tech. AlSaleh shares her expertise on maintaining data integrity in this new era of AI and changing policies.

Exclusive Pharmatica Content

Explore expert-led podcasts, pharmaceutical intelligence, life sciences insights and research-driven analysis from leading industry voices. Pharmatica delivers trusted biotech news, drug development trends and commercial intelligence for professionals across the pharmaceutical sector.

Nicole Dale

Corpus Healthy Human Protein Atlas Gives AI a Better Map

Pharmatica image of a modern proteomics laboratory with analytical equipment representing the mapping of healthy human proteins for AI-driven drug discovery.

The healthy human protein atlas from Ambitious Bio could sharpen target safety checks in AI drug discovery. Explore the claims, the gaps, and the questions to ask.

Nicole Dale

Camizestrant Approval: First ctDNA-Guided Cancer Care

Pharmatica image of a gloved hand holding a blood sample tube in a bright laboratory with red and pink tones and the Pink Breast Cancer Awareness ribbon.

The camizestrant FDA approval is the first for a ctDNA-guided cancer treatment. Find out why the FDA overruled its own advisers and what sponsors must plan next.

How Sensor-Enhanced Patient Data Completes the Story of the Trial

How much can clinical trials miss when researchers rely solely on patient-reported outcomes? Dr Helen Brooker, Director of Product and Clinical Data at Signant Health, joins Trisha Pillay to discuss how wearable sensors complement electronic clinical outcome assessments (eCOA).

Nicole Dale

Novo Bets on AI Drug Discovery as GLP-1 Patents Near Expiry

Pharmatica image of laboratory workstation where digital molecular data is reviewed on a screen in a bright pharmaceutical laboratory, representing AI drug discovery.

AI drug discovery is moving into strategy at Novo. See its 2026 AI milestones, what they prove, and the questions R&D teams should ask before copying them.

Nicole Dale

AI Breast Cancer Screening Moves From Trials to Policy

Pharmatica image of a bright radiology suite lit by natural light, with a soft blue imaging display and a glowing yellow highlight representing AI innovation in breast cancer screening.

AI breast cancer screening finds more cases and cuts radiologist workload, but recall risks remain. See what MASAI, AITIC, and EDITH mean for MedTech teams.

Nicole Dale

Continuous Manufacturing of Biologics Is Ready to Scale

Pharmatica image of a stainless-steel bioreactor and connected equipment in a bright biopharmaceutical manufacturing facility, illustrating continuous biologics production.

Continuous manufacturing of biologics could cut facility costs by up to 50%. Learn what ICH Q13 and the latest evidence mean for pharma teams.

Nicole Dale

CRA-CRC Training for Closing the Sponsor-Site Gap

Pharmatica image of clinical trial outcomes charts reviewed in a bright clinical research setting, representing evidence-led decisions in clinical development.

CRA-CRC training can rebuild sponsor-site trust that remote monitoring weakened. Find out what a 2026 study found and how clinical teams can act on it.

Nicole Dale

The FDA Rare Disease Framework Initiative Explained

Pharmatica image of six red visual elements converging into a unified framework, illustrating the FDA’s six commitments to improving rare-disease regulatory review.

The FDA Rare Disease Framework Initiative aims to make rare disease drug review more consistent. Explore the six commitments and what sponsors should do now.

Nicole Dale

Target Atlas for Smarter Target Prioritisation for Parkinson’s

Pharmatica image of scientific papers, a glass slide, and laboratory glassware on a bright research desk, representing evidence review for Parkinson’s drug target prioritisation.

Target prioritisation gets an evidence upgrade. Find out how Phylo’s Target Atlas and the MJFF Parkinson’s edition rank disease drug targets.

Nicole Dale

SynthID Bio: Watermarking AI-Designed Proteins

Pharmatica image of a photorealistic blue protein structure with a subtle yellow highlight representing AI-designed protein watermarking and biological provenance.

SynthID Bio embeds hidden watermarks in AI-designed proteins. See how Google DeepMind’s tool could strengthen biosecurity and what pharma R&D should do next.

Nicole Dale

Strait of Hormuz Closure Threatens Pharma Supply Chains

Pharmatica image of a container ship navigating a strategic maritime route, illustrating geopolitical risks to pharmaceutical supply chains.

Closures around the Strait of Hormuz create growing pharma supply chain risks. Find out how energy, API, and freight shocks spread and how to build resilience.

Nicole Dale

Quality-of-Life Measurement in Patients With Metastatic Breast Cancer

Pharmatica image of patient questionnaire and clinical research documents illustrating quality-of-life measurement in metastatic breast cancer trials.

The EORTC QLQ-MBR44 is the first quality of life module for metastatic breast cancer. See what 228 interviews reveal and what it means for trial sponsors.

Content type

Topic

Articles, expert interviews, and insights from life sciences leaders

How AI Is Shaping the Next Generation of Clinical Trials

Corpus Healthy Human Protein Atlas Gives AI a Better Map

Camizestrant Approval: First ctDNA-Guided Cancer Care

How Sensor-Enhanced Patient Data Completes the Story of the Trial

Novo Bets on AI Drug Discovery as GLP-1 Patents Near Expiry

AI Breast Cancer Screening Moves From Trials to Policy

Continuous Manufacturing of Biologics Is Ready to Scale

CRA-CRC Training for Closing the Sponsor-Site Gap

The FDA Rare Disease Framework Initiative Explained

Target Atlas for Smarter Target Prioritisation for Parkinson’s

SynthID Bio: Watermarking AI-Designed Proteins

Strait of Hormuz Closure Threatens Pharma Supply Chains

Quality-of-Life Measurement in Patients With Metastatic Breast Cancer